Skip to main navigation Skip to search Skip to main content

Randomized, Open-Label, Phase 3 Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel plus Carbolatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with S

Project: Research

Project Details

StatusFinished
Effective start/end date02/18/09 → 04/10/14

Funding

  • Eli Lilly and Company: $81,307.24